TSXV:RTI.H - Post by User
Comment by
4coffeeson May 23, 2018 9:03pm
165 Views
Post# 28072763
RE:RE:RE:RE:RE:License
RE:RE:RE:RE:RE:License
From RTI’s news release in April. As of February RTI was in the review phase of its application for the ACMPR liscence. Licence is dependent among security upgrades, not completion of plant. Liscence can be approved in June if security upgrades are complete.
Licensing and Plant Expansion Project
The Company, having received its Dealer’s License from Health Canada’s Office of Controlled Substances for its Research & Development Laboratory located at 8223 Roper Road in February 2018, is in the review phase of its application to the Office of Medical Cannabis for the ACMPR Production License (the “ACMPR License”) for its manufacturing facility located at 4035 101 St NW in Edmonton. Approval of the ACMPR License is dependent upon, among other things, security upgrades included in the Company’s previously announced plant expansion and optimization project,